Please use this identifier to cite or link to this item: http://hdl.handle.net/10603/360304
Title: Determination and characterization of heteroresisitant vancomycin intermediate staphylococcus aureus from a tertiary care centre
Researcher: Yamuna Devi B
Guide(s): Balaji V and Shalini Anandan
Keywords: Clinical Medicine
Clinical Pre Clinical and Health
Medicine Research and Experimental
University: The Tamil Nadu Dr. M.G.R. Medical University
Completed Date: 2018
Abstract: The study aimed to characterize the hVISA isolated from the patient identified with MRSA bacteremia. It was also proposed to identify the association between invasive MRSA isolates and the virulence factors PVL and sasX. The potential synergy between oxacillin and vancomycin was also investigated in this study. The study was also intended to understand the epidemiology of MRSA in causing BSI and the genomic comparison of ST772 S. aureus contributes for evolution and expansion. To summarise, increased resistance to clindamycin and trimethoprim-sulfamethoxazole greatly limits the treatment option preferred for treating CA-MRSA infections. It is imperative that high proportion of hVISA is observed among MRSA with the vancomycin MIC of and#8805; 1.5 and#956;g/ml. Increased glycopeptide usage might serve as selection pressure for emergence of hVISA. Clonal association of hVISA, indicates the need of prevention control in practice. The proportion of PVL carrying strains are almost similar between CA and HA-MRSA. The PVL encoding phages and#934;IND772 and and#981;sa119 contributes for the widespread dissemination of PVL in S. aureus strains. In-vitro synergy testing revealed that the combination of beta-lactam plus vancomycin is more bactericidal than vancomyin alone. The presence invasion factors encoding gene sesI and colonisation-invasion virulence factor sasX promotes colonisation mediated invasive MRSA infection and may worsen the clinical outcome. Among MRSA, ST772, ST22 and ST239 were observed as the major clone. The community acquired clone ST772 and the hospital acquired clone are ST239 more multi-drug resistant. The MRSA lineage ST772-SCCmec V is observed as the established multi-drug resistant and highly virulent MRSA clone in India. Acquisition of integrated resistance plasmid and smaller SCCmec variant SCCmec V contributes for the fitness cost to ST772 MRSA strains. Expansion of ST772 strains into hospital is alarming and should be closely monitored for infection prevention control practices. newline
Pagination: 406
URI: http://hdl.handle.net/10603/360304
Appears in Departments:Department of Medical

Files in This Item:
File Description SizeFormat 
01_title.pdfAttached File169.3 kBAdobe PDFView/Open
02_certificates.pdf1.41 MBAdobe PDFView/Open
03_preliminary pages.pdf541.69 kBAdobe PDFView/Open
04_chapter 1.pdf368.43 kBAdobe PDFView/Open
05_chapter 2.pdf231.24 kBAdobe PDFView/Open
06_chapter 3.pdf995.74 kBAdobe PDFView/Open
07_chapter 4.pdf470.52 kBAdobe PDFView/Open
08_chapter 5.pdf892.7 kBAdobe PDFView/Open
09_chapter 6.pdf3.77 MBAdobe PDFView/Open
10_references.pdf725.46 kBAdobe PDFView/Open
11_annexures.pdf7.72 MBAdobe PDFView/Open
80_recommendation.pdf703.17 kBAdobe PDFView/Open
Show full item record


Items in Shodhganga are licensed under Creative Commons Licence Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0).

Altmetric Badge: